Iranian Society of Gynecology Oncology

Document Type : Original Research Article

Author

Department of Obstetrics and Gynecology, School of Medicine, Alexandria University, Alexandria, Egypt

Abstract

Background & Objective: The present study compares between superficial and deep myometrial invasion in type 1 endometrial cancer in relation to regional lymph nodes metastasis, so we can answer the question to do or not do lymphadenectomy, this life-threatening procedure in both superficial and deep myometrial invasion with type 1, clinically and radiologically stage 1 endometrial cancer.
Materials & Methods: Patients were divided into 2 groups distributed as follows: group I includes 50 patients type 1 endometrial cancer with superficial myometrial invasion and group II includes 50 patients type 1 endometrial cancer with deep myometrial invasion. Total abdominal hysterectomy with bilateral salpingo-opherectomy with pelvic and lower para-aortic lymphadenectomy to all patients included in the study from both groups. Histopathological examinations were done to all the specimen from both groups to confirm diagnosis of type 1 endometrial cancer, depth of myometrial invasion, pathological grading and metastasis to the regional lymph nodes.
Results: Considering regional lymph nodes metastasis in both groups, there is a statistical difference between group I and group II in relation to regional lymph nodes metastasis as group II (cases with deep myometrial invasion) are associated with more regional lymph nodes metastasis (P= 0.0001)).
Conclusion: Deep myometrial invasion in type 1 endometrial cancer is associated with significant increase in regional lymph nodes metastases.

Highlights

 Deep myometrial invasion in type 1 endometrial cancer is associated with significant increase in regional lymph nodes metastases.

Keywords

Main Subjects

1. Zhang S, Gong T-T, Liu F-H, Jiang Y-T, Sun H, Ma X-X, et al. Global, regional, and national burden of endometrial cancer, 1990-2017: results from the global burden of disease study, 2017. Front Oncol. 2019;9:1440. [DOI:10.3389/fonc.2019.01440] [PMID] [PMCID]
2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. [DOI:10.3322/caac.21492] [PMID]
3. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983;15(1):10-7. [DOI:10.1016/0090-8258(83)90111-7] [PMID]
4. Moore KN, Fader AN. Uterine papillary serous carcinoma. Clin Obstet Gynecol. 2011;54(2):278-91. [DOI:10.1097/GRF.0b013e318218c755] [PMID]
5. Bakkum-Gamez J, Gonzalez-Bosquet J, Laack N, et al. Current issues in the management of endometrial cancer. Mayo Clin Proc. 2008(83):97-112. [DOI:10.4065/83.1.97] [PMID]
6. American College of Obstetricians and Gynecologists. ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol. 2005;106(2):413-25.
7. Galaal K, Donkers H, Bryant A, Lopes AD. Laparoscopy versus laparotomy for the management of early stage endometrial cancer. Cochrane Database Syst Rev. 2018(10). [DOI:10.1002/14651858.CD006655.pub3] [PMID] [PMCID]
8. Chan JK, Cheung MK, Huh WK, Osann K, Husain A, Teng NN, et al. Therapeutic role of lymph node resection in endometrioid corpus cancer. Cancer. 2006;107(8):1823-30. [DOI:10.1002/cncr.22185] [PMID]
9. Frost JA, Webster KE, Bryant A, Morrison J. Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev. 2017(10). [DOI:10.1002/14651858.CD007585.pub4] [PMID]
10. Zhang G, Chen H, Liu Y, Niu L, Jin L, Li D, et al. Is lymph node dissection mandatory among early stage endometrial cancer patients? A retrospective study. BMC Women's Health. 2020;20(1):258. [DOI:10.1186/s12905-020-01128-w] [PMID] [PMCID]
11. Abu-Rustum NR, Khoury-Collado F, Pandit-Taskar N, Soslow RA, Dao F, Sonoda Y, et al. Sentinel lymph node mapping for grade 1 endometrial cancer: Is it the answer to the surgical staging dilemma? Gynecol Oncol. 2009;113(2):163-9. [DOI:10.1016/j.ygyno.2009.01.003] [PMID] [PMCID]
12. Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang YB, et al. Type I and II endometrial cancers: have they different risk factors? J Clin Oncol. 2013;31(20):2607-18. [DOI:10.1200/JCO.2012.48.2596] [PMID] [PMCID]
13. Seracchioli R, Solfrini S, Mabrouk M, Facchini C, Di Donato N, Manuzzi L, et al. Controversies in Surgical Staging of Endometrial Cancer. Obstet Gynecol Int. 2010;2010:181963. [DOI:10.1155/2010/181963] [PMID] [PMCID]
14. May K, Bryant A, Dickinson HO, Kehoe S, Morrison J. Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev. 2010(1):Cd007585. [DOI:10.1002/14651858.CD007585.pub2]
15. Ignatov A, Lebius C, Ignatov T, Ivros S, Knueppel R, Papathemelis T, et al. Lymph node micrometastases and outcome of endometrial cancer. Gynecol Oncol. 2019;154(3):475-9. [DOI:10.1016/j.ygyno.2019.07.018] [PMID]
16. Euscher E, Fox P, Bassett R, Al-Ghawi H, Ali-Fehmi R, Barbuto D, et al. The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma. Am J Surg Pathol. 2013;37(11):1728-36. [DOI:10.1097/PAS.0b013e318299f2ab] [PMID] [PMCID]
17. Essmat A. Correlation between depth of myometrial invasion and degree of lymph node affection in cases of endometrial cancer. J Obstet Gynaecol. 2021;11(04):360. [DOI:10.4236/ojog.2021.114036]
18. Bandala-Jacques A, Cantú-de-León D, Pérez-Montiel D, Salcedo-Hernández RA, Prada D, González-Enciso A, et al. Diagnostic performance of intraoperative assessment in grade 2 endometrioid endometrial carcinoma. World J Surg Oncol. 2020;18(1):284. [DOI:10.1186/s12957-020-02056-7] [PMID] [PMCID]
19. Ahmet Taner T, Burcu Aykan Y, Işın U, Deniz H, Mustafa Alper K, Ömer Lütfi T, et al. Creating a risk model to determine paraaortic lymph node involvement in endometrial carcinoma. Turk J Med Sci. 2012;42 (Sup.1):1259-67.